AI-Powered PET scans could revolutionize prostate cancer monitoring
NCT ID NCT03594760
First seen Mar 27, 2026 · Last updated May 17, 2026 · Updated 7 times
Summary
This study aims to improve how doctors predict prostate cancer progression and treatment response by combining advanced PSMA-PET scans with artificial intelligence. Researchers will collect scan data from 1,000 men with prostate cancer and use deep learning to discover imaging biomarkers that forecast survival and disease spread. The goal is to help personalize treatment decisions without directly testing a new therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier de l'université de Montréal
RECRUITINGMontreal, Quebec, H2X 0C1, Canada
Conditions
Explore the condition pages connected to this study.